S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.46
+1.78
+10.67%
SVRA · Savara Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$4.67
-0.10
(-2.20%)
● At close: October 21 at 4:00:00 PM EDT
$4.76
+0.09
(+1.93%)
Overnight:
12:44:36 AM EDT
DAY'S RANGE
$4.67
$4.66
$4.95
52-WEEK RANGE
$4.67
$3.50
$7.00
What's happening
- SVRA is down 2.20% today, trading at $4.67. — Live quote
- Volume today (159,152) is well below its 3-month average of 1,909,990. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (after market close), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.16 actual vs. $-0.15 estimated (-10.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 8
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SVRA
-23.22%
vs S&P 500
-35.62%
1-YEAR RETURN
SVRA
+28.25%
vs S&P 500
+12.89%
6-MONTH RETURN
SVRA
-21.12%
3-MONTH RETURN
SVRA
-15.66%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.16
Est. $-0.15
MISS -10.2%
2026-04-26 (Q1 2026)
$-0.15
Est. $-0.14
MISS -9.2%
2026-01-26 (Q4 2025)
$-0.13
Est. $-0.12
MISS -8.2%
2025-10-26 (Q3 2025)
$-0.14
Est. $-0.14
MISS -3.5%
Valuation Measures & Ratios
Enterprise Value4$972.5M
Forward P/E5—
PEG Ratio6-0.65
Price / Sales (TTM1)3785.21
Price / Book78.79
EV4 / Revenue3740.24
EV4 / EBITDA—
Profit Margin-4253.85%
Operating Margin-4150.00%
Return on Equity (ROE8)-90.28%
Return on Assets (ROA9)-68.95%
Avg Volume (3M)1,909,990
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.55B | $1.36B | $751.7M | $495.1M | $617.1M |
| P/E | -11.30 | -10.96 | -6.78 | -4.78 | -6.60 |
| Price/Book | 10.82 | 7.72 | 7.96 | 4.11 | 4.17 |
| ROE | -95.69% | -70.37% | -117.44% | -85.93% | -63.22% |
| ROA | -71.55% | -55.89% | -78.66% | -63.22% | -49.38% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short43,563,969
Change from Prior Settlement+0.51%
% of Float—
Days to Cover (Short Ratio)17.24
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +28.3%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -4253.9%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-25; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SVRA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$41.0M | -$39.0M | -$30.3M | -$31.4M | -$28.4M | -$26.4M | -$23.2M | -$22.5M |
| Net income | -$40.2M | -$37.3M | -$29.6M | -$30.4M | -$26.6M | -$24.2M | -$22.2M | -$20.3M |
| EPS (diluted) | $-0.16 | $-0.15 | $-0.14 | $-0.14 | $-0.12 | $-0.11 | $-0.12 | $-0.11 |
| EPS (basic) | $-0.16 | $-0.15 | $-0.14 | $-0.14 | $-0.12 | $-0.11 | $-0.12 | $-0.11 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $192.1M | $221.6M | $253.4M | $140.9M | $163.8M | $189.3M | $212.9M | $238.8M |
| Total liabilities | $48.5M | $45.6M | $50.3M | $46.5M | $43.3M | $41.5M | $41.4M | $39.5M |
| Stockholders' equity | $143.7M | $176.0M | $203.1M | $94.4M | $120.5M | $147.8M | $171.4M | $199.3M |
| Total current assets | $178.3M | $209.3M | $241.6M | $128.2M | $151.0M | $177.4M | $202.1M | $226.4M |
| Total current liabilities | $17.6M | $15.5M | $20.4M | $16.8M | $13.6M | $11.9M | $14.7M | $12.8M |
| Cash & equivalents | $41.8M | $38.8M | $33.2M | $16.3M | $17.4M | $19.6M | $15.1M | $21.4M |
| Marketable securities (current) | $131.2M | $164.0M | $202.5M | $108.1M | $129.0M | $152.9M | $181.2M | $198.0M |
| Property, plant & equipment | $641.0K | $130.0K | $100.0K | $85.0K | $119.0K | $138.0K | $165.0K | $206.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Other non-current assets | $1.9M | $886.0K | $84.0K | $990.0K | $1.0M | $1.0M | $242.0K | $1.1M |
| Accounts payable | $7.0M | $4.5M | $5.8M | $4.1M | $4.7M | $5.6M | $4.5M | $4.6M |
| Accrued liabilities | $10.6M | $11.0M | $14.6M | $12.6M | $8.9M | $6.3M | $10.2M | $8.2M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Long-term debt | $30.1M | $30.1M | $29.9M | $29.8M | $29.7M | $29.5M | $26.6M | $26.6M |
| Other non-current liabilities | $770.0K | — | $0 | $0 | $0 | $44.0K | $87.0K | $128.0K |
| Common stock & paid-in capital | $204.0K | $204.0K | $204.0K | $173.0K | $173.0K | $173.0K | $173.0K | $172.0K |
| Retained earnings | -$685.6M | -$645.4M | -$608.1M | -$575.9M | -$546.3M | -$515.9M | -$489.2M | -$460.2M |
| Accumulated other comprehensive income (loss) | -$534.0K | -$429.0K | -$87.0K | -$155.0K | -$216.0K | -$632.0K | -$750.0K | $299.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$29.7M | -$33.0M | -$25.1M | -$22.5M | -$26.3M | -$27.2M | -$23.3M | -$22.7M |
| Investing cash flow | $32.6M | $38.8M | -$93.6M | $21.5M | $24.3M | $29.3M | $17.9M | -$98.2M |
| Financing cash flow | $189.0K | -$195.0K | $135.6M | -$23.0K | -$49.0K | $2.3M | -$843.0K | $118.3M |
| Free cash flow | -$30.0M | -$33.1M | -$25.1M | -$22.5M | -$26.3M | -$27.2M | -$23.3M | -$22.7M |
| Capital expenditures | $222.0K | $54.0K | $2.0K | $2.0K | $15.0K | $3.0K | -$9.0K | $3.0K |
| Depreciation & amortization | — | — | — | $35.0K | $63.0K | — | — | $33.0K |
| Share-based compensation | $7.8M | $10.7M | $5.4M | $3.4M | $2.7M | $3.0M | $3.0M | $2.4M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Purchases of investments | $19.4M | — | $127.2M | $22.9M | $39.7M | $15.1M | $32.1M | $138.7M |
| Sales/maturities of investments | $0 | $13.1M | $4.3M | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Debt issued | — | — | $0 | $0 | $0 | $29.6M | — | — |
| Debt repaid | — | — | $0 | -$1.0K | $0 | $27.2M | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$123.5M | -$103.2M | -$60.0M | -$38.8M | -$41.5M |
| Net income | -$118.8M | -$95.9M | -$54.7M | -$38.1M | -$43.0M |
| EPS (diluted) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 |
| EPS (basic) | $-0.53 | $-0.48 | $-0.33 | $-0.25 | $-0.32 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $253.4M | $212.9M | $177.6M | $139.8M | $176.6M |
| Total liabilities | $50.3M | $41.4M | $37.2M | $32.0M | $32.1M |
| Stockholders' equity | $203.1M | $171.4M | $140.4M | $107.8M | $144.5M |
| Total current assets | $241.6M | $202.1M | $165.9M | $129.0M | $165.0M |
| Total current liabilities | $20.4M | $14.7M | $10.6M | $5.9M | $14.7M |
| Cash & equivalents | $33.2M | $15.1M | $26.6M | $52.1M | $34.0M |
| Marketable securities (current) | $202.5M | $181.2M | $135.7M | $73.8M | $127.2M |
| Property, plant & equipment | $100.0K | $165.0K | $270.0K | $51.0K | $73.0K |
| Goodwill | — | — | — | — | — |
| Other non-current assets | $84.0K | $242.0K | $387.0K | $116.0K | $251.0K |
| Accounts payable | $5.8M | $4.5M | $3.5M | $1.3M | $1.4M |
| Accrued liabilities | $14.6M | $10.2M | $7.1M | $4.5M | $4.9M |
| Short-term debt | $0 | — | — | — | $8.3M |
| Long-term debt | $29.9M | $26.6M | $26.3M | $26.1M | $17.3M |
| Other non-current liabilities | $0 | $87.0K | $247.0K | $54.0K | $117.0K |
| Common stock & paid-in capital | $204.0K | $173.0K | $140.0K | $116.0K | $116.0K |
| Retained earnings | -$608.1M | -$489.2M | -$393.4M | -$338.7M | -$300.5M |
| Accumulated other comprehensive income (loss) | -$87.0K | -$750.0K | -$271.0K | -$605.0K | $5.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$101.0M | -$89.1M | -$51.1M | -$34.6M | -$40.1M |
| Investing cash flow | -$18.4M | -$39.9M | -$57.1M | $52.6M | -$69.5M |
| Financing cash flow | $137.8M | $117.6M | $82.8M | $87.0K | $120.8M |
| Free cash flow | -$101.1M | -$89.1M | -$51.4M | -$34.6M | -$40.1M |
| Capital expenditures | $22.0K | $25.0K | $296.0K | $9.0K | $57.0K |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $14.4M | $9.9M | $4.2M | $2.0M | $3.3M |
| Deferred income taxes | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — |
| Purchases of investments | $204.9M | $204.9M | $194.2M | $89.4M | $161.1M |
| Sales/maturities of investments | $4.3M | — | — | $11.3M | $8.2M |
| Debt issued | $29.6M | — | — | $26.4M | — |
| Debt repaid | $27.2M | — | — | $26.4M | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SVRA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers76.2%
Shares Outstanding253,569,891
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 24,471,264 | $150.7M | 9.65% | +0.0% | 2026-08-14 |
| Bain Capital Life Sciences Investors, LLC | 17,600,621 | $108.4M | 6.94% | +0.0% | 2026-08-14 |
| Venrock Adviser, LLC | 14,745,943 | $90.8M | 5.82% | +7.3% | 2026-08-14 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 13,569,000 | $83.6M | 5.35% | +0.0% | 2026-08-14 |
| BlackRock, Inc. | 12,494,498 | $77.0M | 4.93% | +10.7% | 2026-08-07 |
| TCG Crossover Management, LLC | 12,362,205 | $76.2M | 4.88% | +0.0% | 2026-08-12 |
| Frazier Life Sciences Management, L.P. | 9,720,852 | $59.9M | 3.83% | +0.0% | 2026-08-14 |
| Polar Capital Holdings Plc | 9,541,786 | $58.8M | 3.76% | +0.0% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,932,545 | $48.9M | 3.13% | +1.9% | 2026-06-30 |
| Nantahala Capital Management, LLC | 6,976,810 | $43.0M | 2.75% | -5.0% | 2026-08-14 |
| State Street Corp | 6,553,348 | $40.4M | 2.58% | -2.3% | 2026-08-07 |
| MARSHALL WACE, LLP | 6,256,989 | $38.5M | 2.47% | +38.6% | 2026-08-13 |
| RTW INVESTMENTS, LP | 5,952,380 | $36.7M | 2.35% | +0.0% | 2026-08-14 |
| Woodline Partners LP | 4,245,119 | $26.1M | 1.67% | +0.0% | 2026-08-14 |
| ORBIMED ADVISORS LLC | 3,959,900 | $24.4M | 1.56% | +523.6% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,872,133 | $23.9M | 1.53% | +7.7% | 2026-08-12 |
| Spruce Street Capital LP | 3,452,576 | $21.3M | 1.36% | +2.1% | 2026-08-13 |
| Rosalind Advisors, Inc. | 3,178,121 | $19.6M | 1.25% | -0.8% | 2026-08-14 |
| EMERALD ADVISERS, LLC | 3,148,439 | $19.4M | 1.24% | -6.6% | 2026-08-05 |
| Pictet Asset Management Holding SA | 2,763,055 | $17.0M | 1.09% | +21.4% | 2026-07-30 |
| Vestal Point Capital, LP | 2,720,000 | $16.8M | 1.07% | +4.6% | 2026-08-14 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,694,812 | $16.6M | 1.06% | -0.6% | 2026-08-14 |
| D. E. Shaw & Co., Inc. | 2,514,998 | $15.5M | 0.99% | +19.1% | 2026-08-14 |
| Affinity Asset Advisors, LLC | 2,512,153 | $15.5M | 0.99% | +0.0% | 2026-08-13 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 2,375,999 | $14.6M | 0.94% | +0.3% | 2026-08-05 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-02-13 to 2026-09-24
Recent transactions
- Insiders have net sold 394,528 shares over the last 182 days, across 0 purchases and 1 sale.
- Most recent: Parker Braden C. (Chief Commercial Officer) — Tax withholding of 29,323 shares on 2026-09-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)394,528 sh(1 txns)
Net Shares-394,528
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Parker Braden C. | Chief Commercial Officer | Tax withholding | 2026-09-24 | 29,323 |
| Lutz Robert Matthew | Chief Fin. & Operating Officer | Grant / award | 2026-07-15 | 35,000 |
| Lowrance David L | Chief Financial Officer | Option exercise | 2026-06-22 | 75,000 |
| McCracken Joseph S | Reporting person | Option exercise | 2026-02-16 | 1,807 |
| RAMSAY DAVID A | Reporting person | Open market sale | 2025-12-19 | 20,000 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER | Gift | 2025-12-16 | 128,995 |
| McCabe Kathleen R. | Chief Legal Officer | Tax withholding | 2025-12-14 | 39,350 |
| Erickson Anne | Chief Business Officer | Tax withholding | 2025-12-14 | 62,960 |
| Hawkins Richard J | Reporting person | Grant / award | 2025-12-09 | 40,000 |
| van Es-Johansson An | Reporting person | Grant / award | 2025-12-09 | 40,000 |
| Elam Nevan C | Reporting person | Grant / award | 2025-12-09 | 40,000 |
| Wasfi Yasmine | Chief Medical Officer | Tax withholding | 2025-12-04 | 21,992 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Parker Braden C. | Chief Commercial Officer | Tax withholding | 29,323 | $5.07 |
| 2026-07-15 | Lutz Robert Matthew | Chief Fin. & Operating Officer | Grant / award | 35,000 | $0.00 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Option exercise | 75,000 | $1.59 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Tax withholding | 21,682 | $5.50 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Option exercise | 129,350 | $1.23 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Tax withholding | 28,928 | $5.50 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Option exercise | 56,937 | $1.11 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Tax withholding | 11,491 | $5.50 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Option exercise | 218,750 | $1.51 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Tax withholding | 60,057 | $5.50 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Option exercise | 12,500 | $4.45 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Tax withholding | 10,114 | $5.50 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Option exercise | 87,650 | $3.35 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Tax withholding | 53,387 | $5.50 |
| 2026-06-22 | Lowrance David L | Chief Financial Officer | Open market sale | 394,528 | $5.68 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Option exercise | 80,684 | $1.51 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Tax withholding | 24,174 | $5.04 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Option exercise | 75,000 | $1.59 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Tax withholding | 23,661 | $5.04 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Option exercise | 130,650 | $1.23 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Tax withholding | 31,885 | $5.04 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Option exercise | 43,063 | $1.11 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Tax withholding | 9,485 | $5.04 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Option exercise | 12,500 | $4.45 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Tax withholding | 11,037 | $5.04 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Option exercise | 24,850 | $3.35 |
| 2026-03-18 | Lowrance David L | Chief Financial Officer | Tax withholding | 16,518 | $5.04 |
| 2026-02-16 | McCracken Joseph S | Reporting person | Option exercise | 1,807 | $1.76 |
| 2025-12-19 | RAMSAY DAVID A | Reporting person | Open market sale | 20,000 | $6.06 |
| 2025-12-16 | Lowrance David L | Chief Financial Officer | Gift | 32,000 | $0.00 |
| 2025-12-16 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Gift | 128,995 | $0.00 |
| 2025-12-14 | Lowrance David L | Chief Financial Officer | Tax withholding | 62,960 | $6.92 |
| 2025-12-14 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Tax withholding | 195,705 | $6.92 |
| 2025-12-14 | Lutz Robert Matthew | Chief Operating Officer | Tax withholding | 67,760 | $6.92 |
| 2025-12-14 | McCabe Kathleen R. | Chief Legal Officer | Tax withholding | 39,350 | $6.92 |
| 2025-12-14 | Erickson Anne | Chief Business Officer | Tax withholding | 62,960 | $6.92 |
| 2025-12-10 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Gift | 23,629 | $0.00 |
| 2025-12-09 | Hawkins Richard J | Reporting person | Grant / award | 40,000 | $0.00 |
| 2025-12-09 | van Es-Johansson An | Reporting person | Grant / award | 40,000 | $0.00 |
| 2025-12-09 | Elam Nevan C | Reporting person | Grant / award | 40,000 | $0.00 |
| 2025-12-09 | RAMSAY DAVID A | Reporting person | Grant / award | 40,000 | $0.00 |
| 2025-12-09 | McCracken Joseph S | Reporting person | Grant / award | 40,000 | $0.00 |
| 2025-12-04 | Wasfi Yasmine | Chief Medical Officer | Tax withholding | 21,992 | $6.37 |
| 2025-12-02 | Elam Nevan C | Reporting person | Option exercise | 5,860 | $1.46 |
| 2025-12-02 | Elam Nevan C | Reporting person | Tax withholding | 1,473 | $5.81 |
| 2025-11-14 | Hawkins Richard J | Reporting person | Option exercise | 5,860 | $1.46 |
| 2025-10-20 | Wasfi Yasmine | Chief Medical Officer | Grant / award | 35,000 | $0.00 |
| 2025-06-20 | Hawkins Richard J | Reporting person | Open market purchase | 48,225 | $2.04 |
| 2025-05-29 | McCracken Joseph S | Reporting person | Open market purchase | 10,000 | $2.08 |
| 2025-03-31 | RAMSAY DAVID A | Reporting person | Open market purchase | 150,000 | $2.77 |
| 2025-02-13 | Lutz Robert Matthew | Chief Operating Officer | Tax withholding | 38,263 | $2.83 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:40 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-25 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-24 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-22 | View on SEC.gov → |
| 2026-06-08 | 8-K | 2026-06-04 | View on SEC.gov → |
| 2026-05-12 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-03-20 | 4 | 2026-03-18 | View on SEC.gov → |
| 2026-03-13 | 8-K | 2026-03-10 | View on SEC.gov → |
| 2026-03-13 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-02-17 | 4 | 2026-02-16 | View on SEC.gov → |
| 2026-01-27 | 8-K | 2026-01-26 | View on SEC.gov → |
| 2026-01-09 | 8-K | 2026-01-09 | View on SEC.gov → |
Recent news
Headlines about SVRA (Savara Inc.). Links open the publisher — we don’t host full articles.
-
Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment
Yahoo Finance · 2026-10-21 -
Savara presents CHEST data before the FDA decision for Savara stock - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20 -
SVRA261120P00006000 interactive stock chart | SVRA Nov 2026 6.000 put stock
Yahoo Finance UK · 2026-10-19 -
SVRA May 2027 3.000 put (SVRA270521P00003000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-19 -
Savara schedules CHEST 2026 presentations for Savara stock
AD HOC NEWS · 2026-10-18 -
SVRA Oct 2026 9.000 call (SVRA261016C00009000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-16 -
SVRA Oct 2026 9.000 call (SVRA261016C00009000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-16 -
SVRA Oct 2026 6.000 put (SVRA261016P00006000) interactive stock chart
Yahoo Finance UK · 2026-10-16
No headlines in this category right now — try “All”.